Gracure Pharmaceuticals Limited — Fluconazole Exporter Profile
Indian Pharmaceutical Exporter · #11 for Fluconazole · $1.7M export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #11 Indian exporter of Fluconazole with $1.7M in export value and 178 verified shipments. Gracure Pharmaceuticals Limited holds a 1.9% market share in Fluconazole exports across 2 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Fluconazole Export Profile: Buyers & Destinations

Where Does Gracure Pharmaceuticals Limited Export Fluconazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $1.7M | 176 | 97.7% |
| PERU | $38.8K | 2 | 2.3% |
Gracure Pharmaceuticals Limited exports Fluconazole to 2 countries. The largest destination is BELGIUM accounting for 97.7% of Gracure Pharmaceuticals Limited's Fluconazole shipments. These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluconazole from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EXPHAR SANIVELLES SUD ZONE II THINES | BELGIUM | $340.6K | 35 |
| NORDIC PHARMACEUTICAL | PERU | $31.3K | 1 |
| NORDIC PHARMACEUTICAL COMPANY | PERU | $7.5K | 1 |
Gracure Pharmaceuticals Limited supplies Fluconazole to 3 buyers globally. The largest buyer is EXPHAR SANIVELLES SUD ZONE II THINES (BELGIUM), followed by NORDIC PHARMACEUTICAL (PERU) and NORDIC PHARMACEUTICAL COMPANY (PERU). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluconazole Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $51.2M worth of Fluconazole through 8,777 shipments from 660 suppliers to 153 countries, serving 1,471 buyers globally. Gracure Pharmaceuticals Limited contributes $1.7M to this total, accounting for 1.9% of India's Fluconazole exports. Gracure Pharmaceuticals Limited ships Fluconazole to 2 countries through 3 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Fluconazole Exports?
Gracure Pharmaceuticals Limited's average Fluconazole shipment value is $9.6K per consignment, based on 178 shipments totaling $1.7M. The largest destination is BELGIUM (97.7% of Gracure Pharmaceuticals Limited's Fluconazole exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Fluconazole Exporters?
Gracure Pharmaceuticals Limited ranks #11 among 660 Indian Fluconazole exporters with a 1.9% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($11.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.3M), AUROBINDO PHARMA LTD ($6.0M). Gracure Pharmaceuticals Limited processed 178 shipments to 2 destination countries.
What Fluconazole Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUCAZOL B/10 CAPSULES (FLUCONAZOLE CAPS | $201.8K | 9 |
| FLUCAZOL FOR ORAL SUSPENSION B/60 ML (FLUCONAZOLE FOR ORAL SUSPENSION 50 MG /5 ML ) | $78.0K | 3 |
| FLUCAZOL FOR ORAL SUSPENSION B 60 ML FLUCONAZOLE FOR ORAL SUSPENSION 50 MG 5 ML | $52.9K | 3 |
| FLUCAZOL B/10 CAPSULES FLUCONAZOLE CAPS | $50.7K | 2 |
| FLUCAZOL B/10 CAPSULES)(FLUCONAZOLE CAPSULES 100 MG)B.NO.AC230215A,AC230216A,M.D.12/23,E.D.11/26 | $50.0K | 1 |
| FLUCAZOL B/10 CAPSULES (FLUCONAZOLE CAPSULES 100 MG) | $50.0K | 1 |
| FLUCAZOL B/10 CAPSULES(FLUCONAZOLE CAPSULES 100MG) B.NO. AC240114AAC240115A M/DT. 05/2024 E/DT. 04/2027 | $50.0K | 1 |
| FLUCAZOL FOR ORAL SUSPENSION B/60ML(FLUCONAZOLE FOR ORAL SUS 50MG/5ML)B.NO.AD230037A TO AD230040A,M.D.12/23,E.D.11/26. | $43.2K | 1 |
| FLUCAZOL FOR ORAL SUSPENSION B/60ML(FLUCONAZOLE FOR ORAL SUSPEN.50MG/5ML)B.NO.AD230031A TO AD230034A,M.D.11/23,E.D.10/26 | $43.1K | 1 |
| FLUCAZOL FOR ORAL SUSPENSION B/60 ML (FLUCONAZOLE FOR ORAL SUSPENSION 50 MG /5 ML ) | $42.5K | 4 |
Gracure Pharmaceuticals Limited exports 122 distinct Fluconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUCAZOL B/10 CAPSULES (FLUCONAZOLE CAPS with 9 shipments worth $201.8K.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Fluconazole Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AUROBINDO PHARMA LIMITED | $2.6M | 104 | 1 | $24.6K |
| 9 | KUSUM HEALTHCARE PRIVATE LIMITED | $2.2M | 182 | 11 | $11.9K |
| 11 | GRACURE PHARMACEUTICALS LIMITED ★ | $1.7M | 178 | 2 | $9.6K |
| 13 | AJANTA PHARMA LIMITED | $1.5M | 88 | 12 | $16.5K |
| 14 | GLOBELA PHARMA PRIVATE LIMITED | $1.5M | 32 | 2 | $45.4K |
Gracure Pharmaceuticals Limited ranks #11 among 660 Indian Fluconazole exporters. Average shipment value of $9.6K compared to the market average of $77.6K. The closest competitors by value are AUROBINDO PHARMA LIMITED and KUSUM HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Fluconazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,099 | 12.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 988 | 11.3% |
| SAHAR AIR | 919 | 10.5% |
| DELHI AIR | 733 | 8.4% |
| NHAVA SHEVA SEA (INNSA1) | 607 | 6.9% |
| JNPT/ NHAVA SHEVA SEA | 339 | 3.9% |
| JNPT | 284 | 3.2% |
| HYDERABAD ICD | 207 | 2.4% |
What Other Antifungals Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these antifungals products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Fluconazole Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Fluconazole, top products include Tramadol, Albendazole, Folic, Melatonin, Celecoxib. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluconazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 178 individual customs records matching Gracure Pharmaceuticals Limited exporting Fluconazole, covering 122 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 153+ countries, 1,471+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluconazole Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Fluconazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Fluconazole Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluconazole. For current shipment-level data, contact TransData Nexus.